Vanguard Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.5M | Buy |
|
|||||
|
2025
Q2 | $15M | Sell |
|
|||||
|
2025
Q1 | $44.1M | Buy |
|
|||||
|
2024
Q4 | $82.7M | Buy |
|
|||||
|
2024
Q3 | $102M | Sell |
|
|||||
|
2024
Q2 | $125M | Buy |
|
|||||
|
2024
Q1 | $145M | Sell |
|
|||||
|
2023
Q4 | $163M | Buy |
|
|||||
|
2023
Q3 | $94.3M | Buy |
|
|||||
|
2023
Q2 | $91.4M | Buy |
|
|||||
|
2023
Q1 | $77.6M | Buy |
|
|||||
|
2022
Q4 | $81.9M | Buy |
|
|||||
|
2022
Q3 | $54.5M | Buy |
|
|||||
|
2022
Q2 | $46.2M | Buy |
|
|||||
|
2022
Q1 | $53.1M | Buy |
|
|||||
|
2021
Q4 | $72.1M | Buy |
|
|||||
|
2021
Q3 | $97M | Buy |
|
|||||
|
2021
Q2 | $142M | Buy |
|
|||||
|
2021
Q1 | $129M | Buy |
|
|||||
|
2020
Q4 | $112M | Buy |
|
|||||
|
2020
Q3 | $43.8M | Sell |
|
|||||
|
2020
Q2 | $40.4M | Buy |
|
|||||
|
2020
Q1 | $25.9M | Buy |
|
|||||
|
2019
Q4 | $40.9M | Buy |
|
|||||
|
2019
Q3 | $18M | Buy |
|
|||||
|
2019
Q2 | $22.5M | Buy |
|
|||||
|
2019
Q1 | $22.2M | Buy |
|
|||||
|
2018
Q4 | $16.9M | Buy |
|
|||||
|
2018
Q3 | $23.7M | Buy |
|
|||||
|
2018
Q2 | $16.7M | Buy |
|
|||||
|
2018
Q1 | $12.6M | Buy |
|
|||||
|
2017
Q4 | $2.56M | Buy |
|
|||||
|
2017
Q3 | $1.1M | Buy |
|
|||||
|
2017
Q2 | $602K | Sell |
|
|||||
|
2017
Q1 | $1.4M | Buy |
|
|||||
|
2016
Q4 | $2.51M | Sell |
|
|||||
|
2016
Q3 | $5.85M | Buy |
|
|||||
|
2016
Q2 | $4.43M | Buy |
|
|||||
|
2016
Q1 | $3.9M | Buy |
|
|||||
|
2015
Q4 | $5.27M | Buy |
|
|||||
|
2015
Q3 | $3.84M | Buy |
|
|||||
|
2015
Q2 | $165K | Buy |
|